On a roll, Vertex grabs FDA OK for CF double shot Symdeko — prices at $292,000
Close on the heels of its impressive data on new triple combos for cystic fibrosis, Vertex reported out today that the FDA has approved …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
